[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07412743":3,"trial-entities:NCT07412743":87,"trial-summary:NCT07412743":91},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":20,"primary_purpose":21,"phases":22,"enrollment_info":24,"interventions":27,"primary_outcomes":42,"secondary_outcomes":47,"sex":56,"minimum_age":57,"maximum_age":58,"healthy_volunteers":59,"eligibility_criteria":60,"std_ages":67,"locations":70,"central_contacts":80,"overall_officials":81,"references":85,"see_also_links":86},"NCT07412743","R01MD019038-01A1","Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers","ENROLLING_BY_INVITATION","2029-06","2026-04","2026-05-01","2026-01-12","Kaiser Permanente","OTHER",true,"School-based health centers (SBHCs) are an important setting to improve health through detecting, managing and preventing chronic illness. Too few people are educated about the human papillomavirus (HPV), which can prevent tens of thousands of deaths from cancer each year. PEER will evaluate a program to increase health and wellness and the use of SBHCs for primary and preventive care. If successful, PEER could significantly increase the use of SBHCs, and decrease HPV-associated cancers and, thus, reduce the burden of cancer in the United States.",null,[18],"School Health Services",[],"INTERVENTIONAL","PREVENTION",[23],"NA",{"count":25,"type":26},4000,"ESTIMATED",[28,34,38],{"type":29,"name":30,"description":31,"armGroupLabels":32},"BEHAVIORAL","Mailers","Letter and fact sheet (infographic) mailed to caregivers of 9-14 year-olds and to teens 15-18, with optional phone call for \"confidential patients\" aged 15-18.",[33],"Intervention (post-implementation)",{"type":29,"name":35,"description":36,"armGroupLabels":37},"Provider Materials","Clinic team\u002Fstaff training based on qualitative interviews, recommended strategies and evidence-based interventions. Training materials include FAQs and Smart phrases. FAQs and informational sheets containing the same content as the mailers distributed in clinic to teen SBHC patients and their caregivers.",[33],{"type":29,"name":39,"description":40,"armGroupLabels":41},"Peer-to-Peer Educational Sessions","Educational sessions delivered in schools by OSBHA interns. Session content includes SBHC information and HPV awareness.",[33],[43],{"measure":44,"description":45,"timeFrame":46},"Rate of Vaccination for HPV (n of patients with HPV vaccination\u002Fn of patients eligible for vaccination)","Vaccination among eligible clinic patients, and time to vaccination","6 and 12 months",[48,51,54],{"measure":49,"description":50,"timeFrame":46},"Rates of new patients to the clinic (n of new patients\u002Fn of established patients)","New patients seen (vs. prior seen pts.) - New patient characteristics (age, rural)",{"measure":52,"description":53,"timeFrame":46},"Rate of use of other SBHC services (primary care visits, wellness assessments) (n of patients with primary care visits\u002Fn of new and established patients)","Use of other SBHC services and visits among eligible clinic patients",{"measure":55,"description":45,"timeFrame":46},"Rate of vaccination for other adolescent vaccinations (COVID-19, flu, Meningitis, or uptick of other vax's (TDAP, MMR, etc.)) (n of patients with additional vaccination among new and eligible clinic patients)","ALL","9 Years","18 Years",false,{"inclusion":61,"exclusion":65,"raw_text":66},[62,63,64],"Aged 9-18","New or established patients","Flagged if due for an HPV vaccine",[],"Inclusion Criteria:\n\n* Aged 9-18\n* New or established patients\n* Flagged if due for an HPV vaccine\n\nExclusion Criteria:\n\n\\- None",[68,69],"CHILD","ADULT",[71],{"facility":72,"city":73,"state":74,"zip":75,"country":76,"geoPoint":77},"Kaiser Permanente Center for Health Research","Portland","Oregon","97227","United States",{"lat":78,"lon":79},45.52345,-122.67621,[],[82],{"name":83,"affiliation":12,"role":84},"Amanda Petrik, PhD","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":88,"biomarkers":90},[89],"Human Papillomavirus Infection",[],{"nct_id":4,"found":59,"summary":16,"prompt_version":16}]